Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

DR Camidge; EQ Lee; NU Lin; K Margolin; MS Ahluwalia; M Bendszus; SM Chang; J Dancey; EGE de Vries; GJ Harris; FS Hodi; AB Lassman; DR Macdonald; DM Peereboom; D Schiff; R Soffietti; Martin van den Bent; JS Wefel; PY Wen

doi:10.1016/S1470-2045(17)30693-9

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

DR Camidge, EQ Lee, NU Lin, K Margolin, MS Ahluwalia, M Bendszus, SM Chang, J Dancey, EGE de Vries, GJ Harris, FS Hodi, AB Lassman, DR Macdonald, DM Peereboom, D Schiff, R Soffietti, Martin van den Bent, JS Wefel, PY Wen

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

84 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E20-E32
Journal	Lancet Oncology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(17)30693-9
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1016/S1470-2045(17)30693-9

http://hdl.handle.net/1765/112632

Cite this

Camidge, DR., Lee, EQ., Lin, NU., Margolin, K., Ahluwalia, MS., Bendszus, M., Chang, SM., Dancey, J., de Vries, EGE., Harris, GJ., Hodi, FS., Lassman, AB., Macdonald, DR., Peereboom, DM., Schiff, D., Soffietti, R., van den Bent, M., Wefel, JS., & Wen, PY. (2018). Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncology, 19(1), E20-E32. https://doi.org/10.1016/S1470-2045(17)30693-9

@article{ad8448975b404352864c35296a42fbbb,

title = "Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group",

author = "DR Camidge and EQ Lee and NU Lin and K Margolin and MS Ahluwalia and M Bendszus and SM Chang and J Dancey and {de Vries}, EGE and GJ Harris and FS Hodi and AB Lassman and DR Macdonald and DM Peereboom and D Schiff and R Soffietti and {van den Bent}, Martin and JS Wefel and PY Wen",

year = "2018",

doi = "10.1016/S1470-2045(17)30693-9",

language = "Undefined/Unknown",

volume = "19",

pages = "E20--E32",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "1",

}

Camidge, DR, Lee, EQ, Lin, NU, Margolin, K, Ahluwalia, MS, Bendszus, M, Chang, SM, Dancey, J, de Vries, EGE, Harris, GJ, Hodi, FS, Lassman, AB, Macdonald, DR, Peereboom, DM, Schiff, D, Soffietti, R, van den Bent, M, Wefel, JS & Wen, PY 2018, 'Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group', Lancet Oncology, vol. 19, no. 1, pp. E20-E32. https://doi.org/10.1016/S1470-2045(17)30693-9

TY - JOUR

T1 - Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

AU - Camidge, DR

AU - Lee, EQ

AU - Lin, NU

AU - Margolin, K

AU - Ahluwalia, MS

AU - Bendszus, M

AU - Chang, SM

AU - Dancey, J

AU - de Vries, EGE

AU - Harris, GJ

AU - Hodi, FS

AU - Lassman, AB

AU - Macdonald, DR

AU - Peereboom, DM

AU - Schiff, D

AU - Soffietti, R

AU - van den Bent, Martin

AU - Wefel, JS

AU - Wen, PY

PY - 2018

Y1 - 2018

U2 - 10.1016/S1470-2045(17)30693-9

DO - 10.1016/S1470-2045(17)30693-9

M3 - Article

SN - 1470-2045

VL - 19

SP - E20-E32

JO - Lancet Oncology

JF - Lancet Oncology

IS - 1

ER -